Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow Reinvestment Rate
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Reinvestment Rate of 1.76x as of March 2025, reinvesting Rs8.20 Billion (capex Rs2.72 Billion plus investments Rs-5.48 Billion) from operating cash flow of Rs4.65 Billion. Explore AKUMS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Akums Drugs and Pharmaceutical across 4 annual periods. Also explore AKUMS total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year capital reinvestment analysis for Akums Drugs and Pharmaceutical. For live market cap and broader valuation context, see AKUMS company net worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.76x | Rs8.20 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +36.9% |
| 2024 | 1.29x | Rs6.42 Billion | Rs4.98 Billion | Rs3.11 Billion | ▼ -64.1% |
| 2023 | 3.59x | Rs6.33 Billion | Rs1.77 Billion | Rs3.29 Billion | ▼ -76.8% |
| 2022 | 15.46x | Rs4.92 Billion | Rs318.54 Million | Rs2.58 Billion | — |